Pharmaceutical

AstraZeneca scores its second paediatric approval for Soliris in Japan

Soliris is already approved to treat refractory generalised myasthenia gravis in adults in different regions.

Aug 26, 2023 - 20:00
AstraZeneca scores its second paediatric approval for Soliris in Japan
Soliris is already approved to treat refractory generalised myasthenia gravis in adults in different regions.
Read the original article

Tags:

Previous Article

Microbiome company Enterome plans $108m raise to fund Phase II cancer trials

Next Article

Wegovy can reduce heart failure symptoms in obese patients, study shows

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Life scientists’ flight to biotech labs stalls important academic research

STAT+: Life scientists’ flight to biotech labs stalls i...

Nov 15, 2023

STAT+: Cambridge announced as ‘investor catalyst’ hub for ARPA-H

STAT+: Cambridge announced as ‘investor catalyst’ hub f...

Sep 26, 2023

US Elections: how healthcare could look under a Harris or Trump administration

US Elections: how healthcare could look under a Harris ...

Oct 20, 2024